The long-term survival of baboon-to-monkey kidney and liver xenografts

Xenotransplantation

Volumn 10, Issue 5, 2003, Pages 398-409

  Zhong, Robert ^a,b,c   Tucker, Jane ^a,b,c   Zhang, Zheng ^a,f   Wall, William ^a,b   Grant, David ^a,c,e,f   Quan, Douglas ^a,b   Garcia, Bertha ^a   Gao, Zu Hua ^c,g   Asfar, Sami ^b,h   Sharpe, Michael ^a   Gelb, Adrian ^a   Bailey, Michele ^a,d   Stiller, Calvin ^c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

^d Animal Health Diagnostic Center   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f TORONTO GENERAL HOSPITAL   (Canada)

^g DALHOUSIE UNIVERSITY   (Canada)

^h KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Baboon; Kidney; Liver; Monkey; Rejection; Xenotransplantation

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RANITIDINE; RAPAMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BABOON; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOLOGY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY GRAFT; LIVER GRAFT; LOW DRUG DOSE; LYMPHOPROLIFERATIVE DISEASE; MALE; MONKEY; NONHUMAN; POSTOPERATIVE CARE; PRIORITY JOURNAL; XENOGRAFT;

ANIMALS; ANTIBODIES, HETEROPHILE; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MACACA FASCICULARIS; MALE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; PAPIO; SIROLIMUS; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 10744229120     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3089.2003.02054.x     Document Type: Article

References (38)

1. CALNE RY. Organ transplantation between widely disparate species. Transpl Proc 1970; 2: 550.
2. STARZL TE, FUNG J, TZAKIS A et al. Baboon-to-human liver transplantation. Lancet 1993; 341: 65.
3. ROSLIN MS, TRANBAUGH RE, PANZA A et al. One-year monkey heart xenograft survival in cyclosporine-treated baboons. Suppression of the xenoantibody response with total-lymphoid irradiation. Transplantation 1992; 54: 949.
4. MCMANUS RP, KINNEY T, KOMOROWSKI R et al. Reversibility of cardiac xenograft rejection in primates. J Heart Lung Transpl 1991; 10: 5678.
5. ZHONG R, TUCKER J, GRANT D et al. Long-term survival and functional tolerance of baboon to monkey kidney and liver transplantation: a preliminary report. Transpl Proc 1996; 28: 762.
6. LUO Y, GRANT D, PHILIPS J. et al. Improved Graft Survival in Pig to Baboon Renal Xenotransplantation. Rome, Italy: XVIII International Congress of the Transplantation Society, 2000 (Abstract PO293W).
7. ZAIDI A, SCHMOECKEL M, BHATTI F et al. Life-supporting pig-to-primate renal xenotransplantation using genetically modified donors. Transplantation 1998; 65: 1584.
8. COZZI E, BHATTI F, SCHMOECKEL M et al. Long-term survival of nonhuman primates receiving life-supporting transgenic porcine kidney xenografts. Transplantation 2000; 15 (70): 15.
9. VIAL CM, OSTLIE DJ, BHATTI FN et al. Life supporting function for over one month of a transgenic porcine heart in a baboon. J Heart Lung Transplant 2000; 19: 224.
10. OSTLIE DJ, COZZI E, VIAL CM et al. Improved Renal Function and Fewer Rejection Episodes Using SDZ RAD Life-Supporting hDAF Pig to Primate Renal Xenotransplantation. Chicago, IL: 18th AST Annual Meeting 1999 (Abstract 445).
11. VIAL CM, OSTLIE DJ, COZZI E et al. Mycophenolic Acid-Sodium (ERL080) Permits Prolonged Function in hDAF Pig to Primate Xenotransplantation. Chicago, IL: 25th ASTS Annual Meeting, 1999 (Abstract 280).
12. ZHOU B, GUO JY, WANG CX, CHEN J. The rapid determination of the ABO group from body fluids (or sains) by dot enzyme-linked immunosorbent assay (dot_ELISA) using enzyme-labeled monoclonal antibodies. J Forensic Sci 1990; 35 (5): 1125.
13. WALL W, GRANT D, DUFF J. et al. Liver transplantation without venous bypass. Transplantation 1987; 43: 56.
14. DAVIS ML, AUSTIN C, MESSMER BL, NICHOLS WK, BONIN AP, BENNETT MJ. IFCC-standardized pediatric reference intervals for 10 serum proteins using Beckman Array 360 system. Clin Biochem 1996; 29 (5): 489-492.
15. ZHANG Z, LAZAROVITS A, GAO Z et al. Prolongation of xenograft survival using monoclonal antibody CD45RB and cyclophosphamide in rat-to-mouse kidney and heart transplant models. Transplantation 2000; 69: 1137.
16. BARTHOLOMEW A, POWELSON J, SACHS D et al. Tolerance in a concordant nonhuman primate model. Transplantation 1999; 68: 1708.
17. SMITH PC, SLADEK NE. Sensitivity of murine B- and T-lymphocytes to oxazaphosphorine and non-oxazaphosphorine nitrogen mustards. Biochem Pharmacol 1985; 34: 3459.
18. STOCKMAN GD, HEIM LR, SOUTH MA et al. Differential effects of cyclophosphamide on the B and T cell compartments of adult mice. J Immunol 1973; 110: 277.
19. HASAN R, VAN DEN BOGAERDE JB, WALLWORK J et al. Evidence that long-term survival of concordant xenografts is achieved by inhibition of antispecies antibody production. Transplantation 1992; 54: 408.
20. MORRIS RE. New small molecule immunosuppressants for transplantation: review of essential concepts. J Heart Lung Transpl 1993; 12: S275.
21. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group. Lancet 1995; 345: 1321.
22. MORRIS RE, HOYT EG, MURPHY MP et al. Mycophenolic acid morpholinoethylester (RS-61443) is a new immunosuppressant that prevents and halts heart allograft rejection by selective inhibition of T- and B-cell purine synthesis. Transpl Proc 1990; 22: 1659.
23. SEHGAL SN, BANSBACH CC. Rapamycin, in vitro profile of a new immunosuppressive macrolide. Ann N Y Acad Sci 1993; 685: 58.
24. MORRIS RE. Rapamycin: FK506's fraternal twin or distant cousin? Immunol Today 1991; 12: 137.
25. CALNE RY, COLLIER DS, LIM S et al. Rapamycin for immunosuppression in organ allografting. Lancet 1989; 2: 227.
26. STEPKOWSKI SM, CHEN H, DALOZE P et al. Rapamycin, a potent immunosuppressive drug for vascularized heart, kidney, and small bowel transplantation in the rat. Transplantation 1991; 51: 22.
27. KAHAN BD. Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Rapamune US Study Group Lancet 2000; 356: 194.
28. MUTHUKKUMAR S, RAMESH TM, BONDADA S. Rapamycin, a potent immunosuppressive drug, causes programmed cell death in B lymphoma cells. Transplantation 1995; 60: 264.
29. NALESNIK MA. Posttransplantation lymphoproliferative disorders (PTLD): current perspectives. Semin Thorac Cardiovasc Surg 1996; 8: 139.
30. PAYA CV, FUNG JJ, NALESNIK MA et al. Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force Mayo Clinic Organized International Consensus Development Meeting. Transplantation 1999; 68: 1517.
31. STEPHEN SE, COHEN JI, TOSATO G et al. Epstein-Barr virus infections; biology pathogenesis, and management. Ann Thorac Surg 1993; 118: 45.
32. CALNE RY, SELLS RA, PENA JR et al. Induction of immunological tolerance by porcine liver allografts. Nature 1969; 223: 472.
33. KAMADA N, WIGHT DG. Antigen-specific immunosuppression induced by liver transplantation in the rat. Transplantation 1984; 38: 217.
34. KAMADA N, DAVIES HS, WIGHT D et al. Liver transplantation in the rat. Biochemical and histological evidence of complete tolerance induction in non-rejector strains. Transplantation 1983; 35: 304.
35. ZIMMERMAN FA, KNOLL PP, DAVIES HS et al. The fate of orthotopic liver allografts in different rat strain combinations. Transpl Proc 1983; 15: 1272.
36. THOMSON AW, DRAKES ML, ZAHORCHAK AF et al. Hepatic dendritic cells: immunobiology and role in liver transplantation. J Leukoc Biol 1999; 66: 323.
37. BUHLER L, BASKER M, ALWAYN IP et al. Coagulation and thrombotic disorders associated with pig organ and hematopoietic cell transplantation in nonhuman primates. Transplantation 2000; 70: 1323.
38. COWAN PJ, AMINIAN A, BARLOW H et al. Renal xenografts from triple-transgenic pigs are not hyperacutely rejected but cause coagulopathy in non-immunosuppressed baboons. Transplantation 2000; 69: 2504.